|
BTBD12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76977999999384E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.765030E-04 |
| Normal-vs-Stage2 |
4.553800E-02 |
| Normal-vs-Stage3 |
3.24389999994956E-06 |
| Normal-vs-Stage4 |
4.33720000000415E-05 |
| Stage1-vs-Stage2 |
3.602000E-01 |
| Stage1-vs-Stage3 |
4.882200E-02 |
| Stage1-vs-Stage4 |
9.875900E-02 |
| Stage2-vs-Stage3 |
3.991700E-02 |
| Stage2-vs-Stage4 |
5.475500E-02 |
| Stage3-vs-Stage4 |
9.025800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0397999999997E-05 |
| Normal-vs-AfricanAmerican |
3.342300E-02 |
| Normal-vs-Asian |
3.996200E-02 |
| Caucasian-vs-AfricanAmerican |
6.397800E-01 |
| Caucasian-vs-Asian |
2.876400E-01 |
| AfricanAmerican-vs-Asian |
7.828000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.187890E-04 |
| Normal-vs-Female |
2.38579999999322E-05 |
| Male-vs-Female |
7.210800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.788500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.14639999995825E-06 |
| Normal-vs-Age(61-80Yrs) |
2.837400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.801600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.359600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.520600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.479200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.412590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.178000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.484800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.005500E-04 |
| Classical-VS-Follicular |
7.746800E-01 |
| Classical-VS-Other |
1.587420E-01 |
| Classical-VS-Normal |
2.600000E-04 |
| Tall-VS-Follicular |
6.161000E-03 |
| Tall-VS-Other |
9.380200E-01 |
| Tall-VS-Normal |
2.26780000001092E-07 |
| Follicular-VS-Other |
2.303800E-01 |
| Follicular-VS-Normal |
1.802140E-03 |
| Other-VS-Normal |
8.624800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.798800E-04 |
| Normal-vs-N1 |
6.44189999999822E-05 |
| N0-vs-N1 |
2.521000E-01 |
|
|
